Citadel Advisors - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALTW and the CUSIP is 363225111. A total of 4 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2014$2,000
-33.3%
200
-33.3%
0.00%
Q1 2014$3,0003000.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2014
NameSharesValueWeighting ↓
MILLENNIUM MANAGEMENT LLC 643,800$1,461,0000.00%
Neuberger Berman Group LLC 129,700$294,0000.00%
Tower Research Capital LLC (TRC) 889$2,0000.00%
UBS AG 1,355$3,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders